Pharmacological enhancement of calcium-activated potassium channel function reduces the effects of repeated stress on fear memory

被引:20
作者
Atchley, Derek [1 ]
Hankosky, Emily R. [1 ]
Gasparotto, Kaylyn [1 ]
Rosenkranz, J. Amiel [1 ]
机构
[1] Rosalind Franklin Univ, Chicago Med Sch, Dept Cellular, N Chicago, IL 60064 USA
基金
美国国家卫生研究院;
关键词
Fear conditioning; Calcium-activated potassium channel; Stress; 1-EBIO; Amygdala-dependent behavior; CA2+-ACTIVATED K+ CHANNELS; LATERAL AMYGDALA; SK CHANNELS; HIPPOCAMPAL; NEURONS; MODULATION; BRAIN; AFTERHYPERPOLARIZATION; EXCITABILITY; RECORDINGS;
D O I
10.1016/j.bbr.2012.03.037
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Repeated stress impacts emotion, and can induce mood and anxiety disorders. These disorders are characterized by imbalance of emotional responses. The amygdala is fundamental in expression of emotion, and is hyperactive in many patients with mood or anxiety disorders. Stress also leads to hyperactivity of the amygdala in humans. In rodent studies, repeated stress causes hyperactivity of the amygdala, and increases fear conditioning behavior that is mediated by the basolateral amygdala (BLA). Calcium-activated potassium (K-Ca) channels regulate BLA neuronal activity, and evidence suggests reduced small conductance K-Ca (SK) channel function in male rats exposed to repeated stress. Pharmacological enhancement of SK channels reverses the BLA neuronal hyperexcitability caused by repeated stress. However, it is not known if pharmacological targeting of SK channels can repair the effects of repeated stress on amygdala-dependent behaviors. The purpose of this study was to test whether enhancement of SK channel function reverses the effects of repeated restraint on BLA-dependent auditory fear conditioning. We found that repeated restraint stress increased the expression of cued conditioned fear in male rats. However, 1-Ethyl-2-benzimidazolinone (1-EBIO, 1 or 10 mg/kg) or CyPPA (5 mg/kg) administered 30 min prior to testing of fear expression brought conditioned freezing to control levels, with little impact on fear expression in control handled rats. These results demonstrate that enhancement of SK channel function can reduce the abnormalities of BLA-dependent fear memory caused by repeated stress. Furthermore, this indicates that pharmacological targeting of SK channels may provide a novel target for alleviation of psychiatric symptoms associated with amygdala hyperactivity. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 47 条
[1]   In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant [J].
Anderson, Neil J. ;
Slough, Scott ;
Watson, William P. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 546 (1-3) :48-53
[2]   Amygdala response in patients with acute PTSD to masked and unmasked emotional facial expressions [J].
Armony, JL ;
Corbo, V ;
Clément, MH ;
Brunet, A .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (10) :1961-1963
[3]  
Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595
[4]  
Chauveau F, 2012, NEUROPSYCHOPHARMACOL
[5]   Inhibitory control of rat lateral amygdaloid projection cells [J].
Chen, JCT ;
Lang, EJ .
NEUROSCIENCE, 2003, 121 (01) :155-166
[6]   Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy [J].
Conrad, CD ;
Magariños, AM ;
LeDoux, JE ;
McEwen, BS .
BEHAVIORAL NEUROSCIENCE, 1999, 113 (05) :902-913
[7]   Chronic cold stress alters prefrontal cortical modulation of amygdala neuronal activity in rats [J].
Correll, CM ;
Rosenkranz, JA ;
Grace, AA .
BIOLOGICAL PSYCHIATRY, 2005, 58 (05) :382-391
[8]   Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression [J].
Drevets, Wayne C. ;
Price, Joseph L. ;
Furey, Maura L. .
BRAIN STRUCTURE & FUNCTION, 2008, 213 (1-2) :93-118
[9]  
DREVETS WC, 1992, J NEUROSCI, V12, P3628
[10]   Functions of SK channels in central neurons [J].
Faber, E. S. Louise ;
Sah, Pankaj .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (10) :1077-1083